-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Maintains Market Outperform on MBX Biosciences, Raises Price Target to $86

Benzinga·05/12/2026 12:35:47
Listen to the news
Citizens analyst Jonathan Wolleben maintains MBX Biosciences (NASDAQ:MBX) with a Market Outperform and raises the price target from $76 to $86.